drugset / Trial / NCT00201123
Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs
Phase 2
Completed
89 enrolled
NYU Langone Health
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This study will evaluate the lung's immune response to mycobacterium tuberculosis (Mtb) infection and will modulate that response with interferon-gamma.
Timeline
- Start
- 2005-04
- Primary completion
- 2007-01
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Interferon gamma-1b | Protein / enzyme biologic | — | Other |